Preterm Fetal Growth Restriction and Developmental Care

早产胎儿生长受限和发育护理

基本信息

  • 批准号:
    6915736
  • 负责人:
  • 金额:
    $ 47.87万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2004
  • 资助国家:
    美国
  • 起止时间:
    2004-07-01 至 2007-05-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Fetal growth restriction (FGR) increases the already substantial risk of prematurity for infants' survival, overall function and later learning competence. Of the 12% of prematurely born infants in the US each year, more than 5% failed to grow appropriately in the womb due to placental insufficiency. These infants present immediate significant challenges to Newborn Intensive Care Units (NICU); more than 70% will go on to develop learning disabilities and require special educational services. It is postulated that the NICU's stressful environment may exacerbate the FGR infant's low threshold of reactivity and jeopardize already compromised brain development. The proposed project will test the effectiveness of an in-NICU intervention for such infants. It will consist of efforts to individualize all care to the infant's thresholds of sensitivity and to thereby improve neural fiber tract development (MRI) and neurophysiologic functioning (EEG). This in turn is expected to result in better behavioral adaptations. Thirty FGR preterm infants will be randomized to either a Developmental Care (E) or Standard Care (C) group. All infants will be studied within 7 days of birth (baseline) and again at 2 weeks corrected age (2w CA) (outcome). The FGR-E group is expected to show better development at 2w CA in the 3 domains to be tested, neurobehavior, electrophysiology, and brain structure. Furthermore, the FGR infants will be compared to a sample of appropriate in growth for gestational age (AGA) preterm infants for whom comparable data are available at both age points from a previous study. The FGR and AGA C and E groups will be compared in order to identify sample specific aspects of the intervention effects. This might lead to better understanding of the intervention's interaction with sample specific risk factors. The relationship and predictive success will be examined among background variables, intervention, and outcomes in the respective domains. Repeated measures multivariate analysis of variance by domain will be employed to assess sample, group and time effects as well as their interactions. Discriminate function analysis, canonical correlation, multiple regression as well as path analysis will be employed in order to model domain and across age relationships, and to predict intervention effectiveness. Results are expected to show brain-based effects of the intervention for the FGR infants, mediated by stress reduction. This is expected to bring them closer in functioning and brain structural development to their AGA peers. The study will be significant in understanding ways to reduce long-term functional morbidities in FGR infants, as well as in identifying opportunities for enhancing last trimester brain development.
描述(由申请人提供):胎儿生长受限(FGR)增加了婴儿生存、整体功能和后期学习能力的早产风险。美国每年12%的早产婴儿中,超过5%由于胎盘功能不全而未能在子宫内正常生长。这些婴儿给新生儿重症监护病房 (NICU) 带来了直接的重大挑战;超过 70% 将继续出现学习障碍并需要特殊教育服务。据推测,新生儿重症监护室的压力环境可能会加剧 FGR 婴儿的低反应阈值,并危及已经受损的大脑发育。拟议的项目将测试新生儿重症监护病房 (NICU) 干预措施对此类婴儿的有效性。它将包括根据婴儿的敏感性阈值对所有护理进行个性化的努力,从而改善神经纤维束发育(MRI)和神经生理功能(EEG)。这反过来又有望带来更好的行为适应。三十名 FGR 早产儿将被随机分配到发育护理 (E) 组或标准护理 (C) 组。所有婴儿将在出生后 7 天内(基线)进行研究,并在 2 周校正年龄 (2w CA) 时再次进行研究(结果)。 FGR-E 组预计在 2w CA 的 3 个待测试领域(神经行为、电生理学和大脑结构)中表现出更好的发育。此外,FGR 婴儿将与适合胎龄生长 (AGA) 的早产儿样本进行比较,早产儿的两个年龄点的可比数据均来自先前的研究。将比较 FGR 和 AGA C 和 E 组,以确定干预效果的样本具体方面。这可能会导致更好地理解干预措施与样本特定风险因素的相互作用。将检查各个领域的背景变量、干预措施和结果之间的关系和预测成功。将采用按领域重复测量的多变量方差分析来评估样本、组和时间效应及其相互作用。将采用判别函数分析、典型相关、多元回归以及路径分析来建模领域和跨年龄关系,并预测干预效果。预计结果将显示通过减轻压力介导的 FGR 婴儿干预措施对大脑的影响。预计这将使他们在功能和大脑结构发育方面更接近 AGA 同龄人。这项研究对于了解减少 FGR 婴儿长期功能发病率的方法以及寻找增强妊娠末期大脑发育的机会具有重要意义。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

HEIDELISE ALS其他文献

HEIDELISE ALS的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('HEIDELISE ALS', 18)}}的其他基金

Preterm Fetal Growth Restriction and Developmental Care
早产胎儿生长受限和发育护理
  • 批准号:
    7933162
  • 财政年份:
    2009
  • 资助金额:
    $ 47.87万
  • 项目类别:
PRETERM FETAL GROWTH
早产胎儿生长
  • 批准号:
    7719320
  • 财政年份:
    2008
  • 资助金额:
    $ 47.87万
  • 项目类别:
PRETERM FETAL GROWTH
早产胎儿生长
  • 批准号:
    7607379
  • 财政年份:
    2007
  • 资助金额:
    $ 47.87万
  • 项目类别:
Does Early Experience Improve Preterm Neurodevelopment?
早期经验能否改善早产神经发育?
  • 批准号:
    7847566
  • 财政年份:
    2006
  • 资助金额:
    $ 47.87万
  • 项目类别:
Does Early Experience Improve Preterm Neurodevelopment?
早期经验能否改善早产神经发育?
  • 批准号:
    7048138
  • 财政年份:
    2006
  • 资助金额:
    $ 47.87万
  • 项目类别:
Does Early Experience Improve Preterm Neurodevelopment?
早期经验能否改善早产神经发育?
  • 批准号:
    7434365
  • 财政年份:
    2006
  • 资助金额:
    $ 47.87万
  • 项目类别:
Does Early Experience Improve Preterm Neurodevelopment?
早期经验能否改善早产神经发育?
  • 批准号:
    7264515
  • 财政年份:
    2006
  • 资助金额:
    $ 47.87万
  • 项目类别:
Does Early Experience Improve Preterm Neurodevelopment?
早期经验能否改善早产神经发育?
  • 批准号:
    7622688
  • 财政年份:
    2006
  • 资助金额:
    $ 47.87万
  • 项目类别:
PRETERM FETAL GROWTH RESTRICTION AND DEVELOPMENT CARE
早产胎儿生长受限和发育护理
  • 批准号:
    7379253
  • 财政年份:
    2006
  • 资助金额:
    $ 47.87万
  • 项目类别:
PRETERM FETAL GROWTH RESTRICTION AND DEVELOPMENT CARE
早产胎儿生长受限和发育护理
  • 批准号:
    7204533
  • 财政年份:
    2005
  • 资助金额:
    $ 47.87万
  • 项目类别:

相似国自然基金

周边与中央视觉拥挤效应的心理物理学与脑机制研究及临床应用
  • 批准号:
    32371097
  • 批准年份:
    2023
  • 资助金额:
    50 万元
  • 项目类别:
    面上项目
MUC5B/Siglec途径对RA-ILD巨噬细胞胞葬的作用机制及临床价值研究
  • 批准号:
    82302605
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
MicroRNA-23a/HMGN2通过染色质重塑调控中性粒细胞抗细菌免疫的作用机制及其临床检测价值研究
  • 批准号:
    82302630
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
联合脑电和眼动信号的多模态情绪识别脑机接口及其临床应用研究
  • 批准号:
    62306120
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
临床药物麝香酮调控基因回路的设计、构建及其用于非酒精性脂肪性肝炎的基因治疗研究
  • 批准号:
    32301217
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Characterization of the Neurobiological Profiles of Young Adults with and without Developmental Language Disorder (DLD)
患有和不患有发育性语言障碍 (DLD) 的年轻人的神经生物学特征的表征
  • 批准号:
    10721464
  • 财政年份:
    2023
  • 资助金额:
    $ 47.87万
  • 项目类别:
Precision brain charts for imaging-genomics of schizophrenia and the psychosis spectrum
用于精神分裂症和精神病谱系成像基因组学的精确脑图
  • 批准号:
    10717605
  • 财政年份:
    2023
  • 资助金额:
    $ 47.87万
  • 项目类别:
Molecular and Cellular Mechanisms of Chromosome 18q23 Dysmyelination
染色体 18q23 髓鞘脱失的分子和细胞机制
  • 批准号:
    10592982
  • 财政年份:
    2023
  • 资助金额:
    $ 47.87万
  • 项目类别:
Examination of gut-microbiome-brain interactions in a novel gene x environment model of neurodevelopmental disorders
在神经发育障碍的新型基因 x 环境模型中检查肠道-微生物组-大脑相互作用
  • 批准号:
    10730191
  • 财政年份:
    2022
  • 资助金额:
    $ 47.87万
  • 项目类别:
Longitudinal Investigation of the Neurobiological Underpinnings of Risk Behavior in ADHD throughout the Adolescent Transition: The Key Role of Cognitive Control and Motivation Network Development
整个青少年过渡期 ADHD 风险行为的神经生物学基础的纵向调查:认知控制和动机网络发展的关键作用
  • 批准号:
    10597855
  • 财政年份:
    2022
  • 资助金额:
    $ 47.87万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了